Optics.org
daily coverage of the optics & photonics industry and the markets that it serves
News
Menu
Carolyn Cross
Carolyn Cross of Ondine Biomedical believes that PDT should be championed for certain treatments, in the absence of better alternatives. Credit: Ondine Biomedical.
Copyright © 2019 SPIE EuropeDesigned by Kestrel Web Services